Table 3.
Genotype and allele frequencies of IL-10 promoter polymorphisms in breast cancer patients and healthy controls
Frequency, no.(%) | Frequency, no.(%) | ||||||
---|---|---|---|---|---|---|---|
Genetype | Patients n = 315 | Controls n = 322 | P-value | Alleles | Patients 2n = 630 | Controls 2n = 644 | P-value |
-1082 A/G | 0.664 | -1082 A/G | 0.374 | ||||
AA | 285 (90.5) | 285 (88.5) | A | 599 (95.1) | 605 (93.9) | ||
AG | 29 (9.2) | 35 (10.9) | G | 31 (4.9) | 39 (6.1) | ||
GG | 1 (0.3) | 2 (0.6) | |||||
-819 T/C | 0.604 | -819 T/C | 0.315 | ||||
TT | 119 (37.8) | 134 (41.6) | T | 373 (59.2) | 399 (62.0) | ||
TC | 135 (42.9) | 131 (40.7) | C | 257 (40.8) | 245 (38.0) | ||
CC | 61 (19.3) | 57 (17.7) | |||||
-592 A/C | 0.604 | -592 A/C | 0.315 | ||||
AA | 119 (37.8) | 134 (41.6) | A | 373 (59.2) | 399 (62.0) | ||
AC | 135 (42.9) | 131 (40.7) | C | 257 (40.8) | 245 (38.0) | ||
CC | 61 (19.3) | 57 (17.7) |